<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02607046</url>
  </required_header>
  <id_info>
    <org_study_id>F1927-P</org_study_id>
    <secondary_id>I21RX001927</secondary_id>
    <nct_id>NCT02607046</nct_id>
  </id_info>
  <brief_title>Exercise Rehabilitation in Veterans With PAD</brief_title>
  <official_title>Post-revascularization Rehabilitation to Improve Function in Veterans With PAD</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VA Office of Research and Development</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>VA Office of Research and Development</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Peripheral artery disease (PAD) results in blockages of arteries (blood vessels) and&#xD;
      decreased blood flow to the legs. This may cause difficulty or pain with walking or other&#xD;
      activities that use leg muscles. Exercise may help improve blood flow in the legs and improve&#xD;
      the ability to walk. This research project will be conducted patients with PAD that require&#xD;
      revascularization. The goal is to examine the effects of 3 months of exercise rehabilitation&#xD;
      or neuromuscular stimulation on leg blood flow, physical function, quality of life and&#xD;
      general health.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Peripheral artery disease (PAD) and its associated declines in physical function impair&#xD;
      quality of life (QOL) in nearly 20% of older Veterans and result in substantial VA health&#xD;
      care costs. Revascularization addresses the anatomical pathology, but does not restore&#xD;
      mobility function and QOL. Optimal therapy may require post-revascularization rehabilitation&#xD;
      to address lingering defects in skeletal muscle that limit function; however, the current&#xD;
      standard of care after revascularization does not include rehabilitation. Exercise training&#xD;
      and neuromuscular electrical stimulation (NMES) may enhance function by increasing muscle&#xD;
      perfusion to improve outcomes in older Veterans with PAD after revascularization.&#xD;
&#xD;
      The investigators will enroll Veterans (50-80 years of age) with PAD who are planned for&#xD;
      percutaneous revascularization. Participants will complete research testing consisting of: a)&#xD;
      Assessment of mobility function and QOL; and b) Treadmill tests to assess ambulatory&#xD;
      capacity, and calf muscle perfusion. Participants will undergo screening prior to&#xD;
      revascularization and will have baseline testing 2-3 weeks after revascularization. After&#xD;
      post-revascularization testing, patients will be randomized to Exercise-only or NMES-only.&#xD;
      After completion of the 3-month intervention, participants will repeat all tests to determine&#xD;
      the effects of the interventions.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">October 1, 2015</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Actual">December 31, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Modified Physical Performance Test</measure>
    <time_frame>3 months</time_frame>
    <description>Test of Mobility Function (minimum score = 0; maximum score = 36; higher score associated with better outcome)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Six-minute Walk Distance</measure>
    <time_frame>3 months</time_frame>
    <description>Test of ambulatory capacity</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Muscle Perfusion Measured by Ultrasound Scan</measure>
    <time_frame>3 months</time_frame>
    <description>Calf Muscle Perfusion assessed as digital video intensity from recorded ultrasound scans. Units are scale data with a minimum = 0 and no predetermined maximum. Higher score = more perfusion.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">35</enrollment>
  <condition>Peripheral Arterial Disease</condition>
  <condition>Intermittent Claudication</condition>
  <arm_group>
    <arm_group_label>Exercise</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Exercise Training</description>
  </arm_group>
  <arm_group>
    <arm_group_label>NMES</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Neuromuscular Electrical Stimulation</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Exercise training</intervention_name>
    <description>The exercise program includes supervised and home-based walking and strength exercise.</description>
    <arm_group_label>Exercise</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>NMES</intervention_name>
    <description>This intervention consists of using neuromuscular electrical stimulation (NMES) as a form of passive exercise for muscles in the legs.</description>
    <arm_group_label>NMES</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Diagnosis of peripheral arterial disease; or ankle-brachial index &lt;0.9.&#xD;
&#xD;
          -  Planned to undergo endovascular revascularization within 6 months.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Cancer under active treatment&#xD;
&#xD;
          -  Planned for lower extremity bypass surgery&#xD;
&#xD;
          -  Body mass index &gt; 45 kg/m2&#xD;
&#xD;
          -  Critical limb ischemia or lower extremity gangrene&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Steven J. Prior, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>November 13, 2015</study_first_submitted>
  <study_first_submitted_qc>November 13, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 17, 2015</study_first_posted>
  <results_first_submitted>December 23, 2020</results_first_submitted>
  <results_first_submitted_qc>January 26, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">February 15, 2021</results_first_posted>
  <last_update_submitted>January 26, 2021</last_update_submitted>
  <last_update_submitted_qc>January 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>rehabilitation</keyword>
  <keyword>exercise training</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Peripheral Arterial Disease</mesh_term>
    <mesh_term>Peripheral Vascular Diseases</mesh_term>
    <mesh_term>Intermittent Claudication</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>March 28, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/46/NCT02607046/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>56 participants enrolled; only 35 participants completed baseline testing and were randomized.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Exercise</title>
          <description>Exercise Training&#xD;
Exercise training: The exercise program includes supervised treadmill walking and home-based walking exercise.</description>
        </group>
        <group group_id="P2">
          <title>NMES</title>
          <description>Neuromuscular Electrical Stimulation&#xD;
NMES: This intervention consists of using neuromuscular electrical stimulation (NMES) as a form of passive exercise for muscles in the legs.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="22"/>
                <participants group_id="P2" count="13"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="14"/>
                <participants group_id="P2" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Exercise</title>
          <description>Exercise Training&#xD;
Exercise training: The exercise program includes supervised treadmill walking and home-based walking exercise.</description>
        </group>
        <group group_id="B2">
          <title>NMES</title>
          <description>Neuromuscular Electrical Stimulation&#xD;
NMES: This intervention consists of using neuromuscular electrical stimulation (NMES) as a form of passive exercise for muscles in the legs.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="22"/>
            <count group_id="B2" value="13"/>
            <count group_id="B3" value="35"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="66.3" spread="5.3"/>
                    <measurement group_id="B2" value="69.7" spread="7.5"/>
                    <measurement group_id="B3" value="67.8" spread="6.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="19"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="16"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="22"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Modified Physical Performance Test</title>
          <description>Test of Mobility Function (minimum score = 0; maximum score = 36; higher score associated with better outcome)</description>
          <units>scores on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="30.8" spread="3.5"/>
                    <measurement group_id="B2" value="30.7" spread="3.0"/>
                    <measurement group_id="B3" value="30.8" spread="3.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Six-minute Walk Distance</title>
          <description>Test of Ambulatory Capacity</description>
          <units>feet</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1237" spread="328"/>
                    <measurement group_id="B2" value="1070" spread="325"/>
                    <measurement group_id="B3" value="1164" spread="330"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Muscle Perfusion Measured by Ultrasound Scan</title>
          <description>Calf Muscle Perfusion assessed as digital video intensity from recorded ultrasound scans. Units are scale data with a minimum = 0 and no predetermined maximum. Higher score = more perfusion.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4.57" spread="1.98"/>
                    <measurement group_id="B2" value="3.90" spread="2.01"/>
                    <measurement group_id="B3" value="4.28" spread="1.90"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Modified Physical Performance Test</title>
        <description>Test of Mobility Function (minimum score = 0; maximum score = 36; higher score associated with better outcome)</description>
        <time_frame>3 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Exercise</title>
            <description>Exercise Training&#xD;
Exercise training: The exercise program includes supervised treadmill walking and home-based walking exercise.</description>
          </group>
          <group group_id="O2">
            <title>NMES</title>
            <description>Neuromuscular Electrical Stimulation&#xD;
NMES: This intervention consists of using neuromuscular electrical stimulation (NMES) as a form of passive exercise for muscles in the legs.</description>
          </group>
        </group_list>
        <measure>
          <title>Modified Physical Performance Test</title>
          <description>Test of Mobility Function (minimum score = 0; maximum score = 36; higher score associated with better outcome)</description>
          <units>scores on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="31.8" spread="5.2"/>
                    <measurement group_id="O2" value="32.3" spread="3.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Six-minute Walk Distance</title>
        <description>Test of ambulatory capacity</description>
        <time_frame>3 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Exercise</title>
            <description>Exercise Training&#xD;
Exercise training: The exercise program includes supervised treadmill walking and home-based walking exercise.</description>
          </group>
          <group group_id="O2">
            <title>NMES</title>
            <description>Neuromuscular Electrical Stimulation&#xD;
NMES: This intervention consists of using neuromuscular electrical stimulation (NMES) as a form of passive exercise for muscles in the legs.</description>
          </group>
        </group_list>
        <measure>
          <title>Six-minute Walk Distance</title>
          <description>Test of ambulatory capacity</description>
          <units>feet</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1295" spread="287"/>
                    <measurement group_id="O2" value="1193" spread="191"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Muscle Perfusion Measured by Ultrasound Scan</title>
        <description>Calf Muscle Perfusion assessed as digital video intensity from recorded ultrasound scans. Units are scale data with a minimum = 0 and no predetermined maximum. Higher score = more perfusion.</description>
        <time_frame>3 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Exercise</title>
            <description>Exercise Training&#xD;
Exercise training: The exercise program includes supervised treadmill walking and home-based walking exercise.</description>
          </group>
          <group group_id="O2">
            <title>NMES</title>
            <description>Neuromuscular Electrical Stimulation&#xD;
NMES: This intervention consists of using neuromuscular electrical stimulation (NMES) as a form of passive exercise for muscles in the legs.</description>
          </group>
        </group_list>
        <measure>
          <title>Muscle Perfusion Measured by Ultrasound Scan</title>
          <description>Calf Muscle Perfusion assessed as digital video intensity from recorded ultrasound scans. Units are scale data with a minimum = 0 and no predetermined maximum. Higher score = more perfusion.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.13" spread="4.75"/>
                    <measurement group_id="O2" value="4.59" spread="2.49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>3 months</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Exercise</title>
          <description>Exercise Training&#xD;
Exercise training: The exercise program includes supervised treadmill walking and home-based walking exercise.</description>
        </group>
        <group group_id="E2">
          <title>NMES</title>
          <description>Neuromuscular Electrical Stimulation&#xD;
NMES: This intervention consists of using neuromuscular electrical stimulation (NMES) as a form of passive exercise for muscles in the legs.</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="13"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="01" subjects_at_risk="22"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="13"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Chest Pain</sub_title>
                <description>Exertional chest pain. Brief hospitalization; no intervention required</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E2" subjects_at_risk="13"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="22"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="13"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Vertigo</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="13"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Elevated Blood Glucose</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="13"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Cyst</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="13"/>
              </event>
              <event>
                <sub_title>Toe injury</sub_title>
                <description>Toe wound unrelated to study</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="13"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Hypotension</sub_title>
                <description>Single bout of hypotension</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="13"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Steven Prior</name_or_title>
      <organization>Department of Veterans Affairs</organization>
      <phone>410-605-7000 ext 54129</phone>
      <email>steven.prior@va.gov</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

